Dudediligence.

Equillium, Inc

EQNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$12.2MSep ’24$4.4MDec ’24
Net income, by quarter
−$7,000Sep ’24−$5.8MDec ’24−$8.7MMar ’25−$5.7MJun ’25−$4.2MSep ’25−$3.8MDec ’25−$5.3MMar ’26−$4.7MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$15.8M$36.1M$41.1Mnone on file
Operating income−$37.8M−$62.1M−$14.5M−$8.3M−$23.6M
Net income−$39.1M−$62.4M−$13.3M−$8.1M−$22.4M
Operating cash flow−$32.1M−$8.7M−$21.8M−$19.0M−$22.7M
Free cash flow−$32.1M−$9.0M−$21.8M−$19.1M−$22.8M
Cash$50.4M$59.1M$23.2M$18.1M$30.3M
Debt$10.2M$9.0Mnone on filenone on filenone on file
Shares outstanding29.5M34.4M35.3M35.6M61.5M